All entries for: Cyclerion Therapeutics, Inc

March 30, 2026

Cyclerion Therapeutics, Inc

Negative Outlook

Cambridge, MA
51-200 employees

The impact of healthcare reform and other governmental and private payor initiatives, as well as the Inflation Reduction Act of 2022, may harm our business.

Disease Area: Cardiology, Neurological Diseases
Drug Type: Small Molecule
Scroll to Top